chr2-222424704-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152386.4(SGPP2):c.102C>A(p.Asn34Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000761 in 1,445,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152386.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGPP2 | NM_152386.4 | c.102C>A | p.Asn34Lys | missense_variant | 1/5 | ENST00000321276.8 | NP_689599.2 | |
SGPP2 | NM_001320833.2 | c.-426C>A | 5_prime_UTR_variant | 1/6 | NP_001307762.1 | |||
SGPP2 | NM_001320834.2 | c.-166+626C>A | intron_variant | NP_001307763.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGPP2 | ENST00000321276.8 | c.102C>A | p.Asn34Lys | missense_variant | 1/5 | 1 | NM_152386.4 | ENSP00000315137.7 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151918Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000619 AC: 8AN: 1293362Hom.: 0 Cov.: 30 AF XY: 0.00000629 AC XY: 4AN XY: 635682
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151918Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74220
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.102C>A (p.N34K) alteration is located in exon 1 (coding exon 1) of the SGPP2 gene. This alteration results from a C to A substitution at nucleotide position 102, causing the asparagine (N) at amino acid position 34 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at